Mx transgenic mice - Animal models of health

H. Arnheiter, M. Frese, R. Kambadur, E. Meier, O. Haller

Research output: Contribution to journalReview article

88 Citations (Scopus)

Abstract

If viruses, by their variety, distribution, potential virulence and sheer inexhaustibility, present a permanent threat to the well-being of organisms, one might wonder why good health still exists. Yet healthy organisms do exist, though not because they simply evade the tireless viral intruders, but because they constantly mobilize potent defense forces. In vertebrates, T and B cell-mediated immunity is usually credited with being of prime importance in antiviral defense, but often, the first hurdles viruses have to clear are not antibodies and T cells but the flow of mucus, the acidity of the stomach, the paucity of appropriate cellular virus receptors, or the inadequacy of a synthetic machinery that viruses need to usurp for their replication. These hurdles are host defense mechanisms no less important for the homeostasis of health than the specific immune system; they are placed at various levels and make the interplay between virus and host a notoriously complex affair. The method of choice to elucidate such defense mechanisms at the molecular level is the analysis of genetic variants in which these defense forces are altered. Although such variants abound from plants (FRASER 1990) to mammals (for mice, see GREEN 1989), only a few of the associated genes have been isolated or characterized (for example, DÉzÉlÉe et al. 1989; Dveksler et al. 1991; Yokomori and Lai 1992; NÉdellec étal. 1994; Bureau et al. 1993), most likely because many of these variants are multigenic in origin and difficult to analyze
Original languageEnglish
Pages (from-to)118-147
Number of pages29
JournalCurrent Topics in Microbiology and Immunology
Volume206
DOIs
Publication statusPublished - 1 Dec 1996
Externally publishedYes

Fingerprint

Genetically Modified Animals
Transgenic Mice
Animal Models
Viruses
Health
Virus Receptors
T-Lymphocytes
Mucus
Cellular Immunity
Antiviral Agents
Virulence
Vertebrates
Mammals
Immune System
Stomach
Homeostasis
B-Lymphocytes
Antibodies
Genes

Cite this

Arnheiter, H. ; Frese, M. ; Kambadur, R. ; Meier, E. ; Haller, O. / Mx transgenic mice - Animal models of health. In: Current Topics in Microbiology and Immunology. 1996 ; Vol. 206. pp. 118-147.
@article{c890332a0ffa40488435e4465254e229,
title = "Mx transgenic mice - Animal models of health",
abstract = "If viruses, by their variety, distribution, potential virulence and sheer inexhaustibility, present a permanent threat to the well-being of organisms, one might wonder why good health still exists. Yet healthy organisms do exist, though not because they simply evade the tireless viral intruders, but because they constantly mobilize potent defense forces. In vertebrates, T and B cell-mediated immunity is usually credited with being of prime importance in antiviral defense, but often, the first hurdles viruses have to clear are not antibodies and T cells but the flow of mucus, the acidity of the stomach, the paucity of appropriate cellular virus receptors, or the inadequacy of a synthetic machinery that viruses need to usurp for their replication. These hurdles are host defense mechanisms no less important for the homeostasis of health than the specific immune system; they are placed at various levels and make the interplay between virus and host a notoriously complex affair. The method of choice to elucidate such defense mechanisms at the molecular level is the analysis of genetic variants in which these defense forces are altered. Although such variants abound from plants (FRASER 1990) to mammals (for mice, see GREEN 1989), only a few of the associated genes have been isolated or characterized (for example, D{\'E}z{\'E}l{\'E}e et al. 1989; Dveksler et al. 1991; Yokomori and Lai 1992; N{\'E}dellec {\'e}tal. 1994; Bureau et al. 1993), most likely because many of these variants are multigenic in origin and difficult to analyze",
author = "H. Arnheiter and M. Frese and R. Kambadur and E. Meier and O. Haller",
year = "1996",
month = "12",
day = "1",
doi = "10.1007/978-3-642-85208-4_8",
language = "English",
volume = "206",
pages = "118--147",
journal = "Ergebnisse der Mikrobiologie, Immunitatsforschung und experimentellen Therapie",
issn = "0070-217X",
publisher = "Springer Verlag",

}

Mx transgenic mice - Animal models of health. / Arnheiter, H.; Frese, M.; Kambadur, R.; Meier, E.; Haller, O.

In: Current Topics in Microbiology and Immunology, Vol. 206, 01.12.1996, p. 118-147.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Mx transgenic mice - Animal models of health

AU - Arnheiter, H.

AU - Frese, M.

AU - Kambadur, R.

AU - Meier, E.

AU - Haller, O.

PY - 1996/12/1

Y1 - 1996/12/1

N2 - If viruses, by their variety, distribution, potential virulence and sheer inexhaustibility, present a permanent threat to the well-being of organisms, one might wonder why good health still exists. Yet healthy organisms do exist, though not because they simply evade the tireless viral intruders, but because they constantly mobilize potent defense forces. In vertebrates, T and B cell-mediated immunity is usually credited with being of prime importance in antiviral defense, but often, the first hurdles viruses have to clear are not antibodies and T cells but the flow of mucus, the acidity of the stomach, the paucity of appropriate cellular virus receptors, or the inadequacy of a synthetic machinery that viruses need to usurp for their replication. These hurdles are host defense mechanisms no less important for the homeostasis of health than the specific immune system; they are placed at various levels and make the interplay between virus and host a notoriously complex affair. The method of choice to elucidate such defense mechanisms at the molecular level is the analysis of genetic variants in which these defense forces are altered. Although such variants abound from plants (FRASER 1990) to mammals (for mice, see GREEN 1989), only a few of the associated genes have been isolated or characterized (for example, DÉzÉlÉe et al. 1989; Dveksler et al. 1991; Yokomori and Lai 1992; NÉdellec étal. 1994; Bureau et al. 1993), most likely because many of these variants are multigenic in origin and difficult to analyze

AB - If viruses, by their variety, distribution, potential virulence and sheer inexhaustibility, present a permanent threat to the well-being of organisms, one might wonder why good health still exists. Yet healthy organisms do exist, though not because they simply evade the tireless viral intruders, but because they constantly mobilize potent defense forces. In vertebrates, T and B cell-mediated immunity is usually credited with being of prime importance in antiviral defense, but often, the first hurdles viruses have to clear are not antibodies and T cells but the flow of mucus, the acidity of the stomach, the paucity of appropriate cellular virus receptors, or the inadequacy of a synthetic machinery that viruses need to usurp for their replication. These hurdles are host defense mechanisms no less important for the homeostasis of health than the specific immune system; they are placed at various levels and make the interplay between virus and host a notoriously complex affair. The method of choice to elucidate such defense mechanisms at the molecular level is the analysis of genetic variants in which these defense forces are altered. Although such variants abound from plants (FRASER 1990) to mammals (for mice, see GREEN 1989), only a few of the associated genes have been isolated or characterized (for example, DÉzÉlÉe et al. 1989; Dveksler et al. 1991; Yokomori and Lai 1992; NÉdellec étal. 1994; Bureau et al. 1993), most likely because many of these variants are multigenic in origin and difficult to analyze

UR - http://www.scopus.com/inward/record.url?scp=0030069417&partnerID=8YFLogxK

U2 - 10.1007/978-3-642-85208-4_8

DO - 10.1007/978-3-642-85208-4_8

M3 - Review article

VL - 206

SP - 118

EP - 147

JO - Ergebnisse der Mikrobiologie, Immunitatsforschung und experimentellen Therapie

JF - Ergebnisse der Mikrobiologie, Immunitatsforschung und experimentellen Therapie

SN - 0070-217X

ER -